Amylyx Pharmaceuticals (AMLX) Current Leases (2022 - 2026)
Amylyx Pharmaceuticals (AMLX) posted quarterly Current Leases of $1.2 million for Q1 2026, up 9.48% year-over-year from $1.1 million in Q1 2025, and down 8.26% quarter-over-quarter from $1.3 million in Q4 2025.
Amylyx Pharmaceuticals (AMLX) Current Leases (2022 - 2026) Analysis & Trends
Amylyx Pharmaceuticals' Current Leases history runs 5 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Current Leases rose 9.48% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (up 9.48% YoY), while the FY2025 annual figure was $1.3 million, down 17.06% from the prior year.
- Current Leases for Q1 2026 stood at $1.2 million, down from $1.3 million in the prior quarter.
- The five-year high for Current Leases was $2.4 million in Q2 2024, with the low at $665000.0 in Q2 2025.
- The 5-year median for Current Leases is $2.0 million (2024), against an average of $1.7 million.
- The sharpest annual moves came in 2023 and 2025: Current Leases surged 48.97% in 2023, then sank 71.93% in 2025.
- Amylyx Pharmaceuticals' Current Leases stood at $2.0 million in 2022, then increased by 10.64% to $2.3 million in 2023, then plunged by 32.74% to $1.5 million in 2024, then slipped by 17.06% to $1.3 million in 2025, then retreated by 8.26% to $1.2 million in 2026.
- Business Quant data shows AMLX's Current Leases at $1.2 million in Q1 2026, $1.3 million in Q4 2025, and $981000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.71 Bn | 42.75 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.11 Bn | 39.45 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.62 Bn | 29.94 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.72 Bn | 22.92 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.10 Bn | 11.57 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amylyx Pharmaceuticals | 4.28 Bn | 4.28 Bn | - | 1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.01 Mn |
| Mar 31, 2026 | 1.16 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 981,000.00 |
| Jun 30, 2025 | 665,000.00 |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | 1.52 Mn |
| Sep 30, 2024 | 1.97 Mn |
| Jun 30, 2024 | 2.37 Mn |
| Mar 31, 2024 | 2.31 Mn |
| Dec 31, 2023 | 2.26 Mn |
| Sep 30, 2023 | 2.20 Mn |
| Jun 30, 2023 | 2.15 Mn |
| Mar 31, 2023 | 2.09 Mn |
| Dec 31, 2022 | 2.04 Mn |
| Sep 30, 2022 | 1.99 Mn |
| Jun 30, 2022 | 1.79 Mn |
| Mar 31, 2022 | 1.41 Mn |